Gemtuzumab Ozogamicin for Injection

Name: Gemtuzumab Ozogamicin for Injection

Indications

Newly-Diagnosed CD33-positive Acute Myeloid Leukemia (AML)

MYLOTARG is indicated for the treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults.

Relapsed Or Refractory CD33-positive AML

MYLOTARG is indicated for the treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and in pediatric patients 2 years and older.

What happens if i miss a dose (mylotarg)?

Contact your doctor if you miss an appointment for your gemtuzumab injection.

(web3)